Atrion Medical Products

Atrion Medical Products is a leading developer and manufacturer of specialized medical devices, operating as a subsidiary of Nordson Corporation following its acquisition in 2024. The company focuses on three primary therapeutic areas: cardiovascular surgery, ophthalmology, and fluid delivery systems. Its flagship products include the Myocardial Protection System (MPS), a market-leading technology for delivering fluids and medications during cardiac procedures, and the LacriCATH balloon catheter for treating nasolacrimal duct obstructions. Beyond its proprietary product lines, Atrion provides comprehensive contract manufacturing services, including cleanroom assembly, injection molding, and sterilization. The company is headquartered in Arab, Alabama, and serves a global customer base of hospitals and medical practitioners.